Last updated on June 2018

Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)


Brief description of study

The purpose this study is to evaluate the efficacy, safety, and pharmacokinetics of GDC-0853 compared with placebo in participants with Chronic Spontaneous Urticaria (CSU) refractory to anti-histamines.

Clinical Study Identifier: NCT03137069

Contact Investigators or Research Sites near you

Start Over

Reference study Id Number: GS39684 ...

Sussman Clinical Research
Toronto, ON Canada
  Connect »

Reference study Id Number: GS39684 ...

Centre de Recherche Applique En Allergie de Quebec
Quebec City, QC Canada
  Connect »

Reference study Id Number: GS39684 ...

Charite Mitte; Klinik fur Dermatologie
Berlin, Germany
  Connect »

Reference study Id Number: GS39684 ...

Universit tsmedizin Johannes Gutenberg Universit t
Mainz, Germany
  Connect »

Reference study Id Number: GS39684 ...

Cheema Research, Inc
Mississauga, ON Canada
  Connect »

Reference study Id Number: GS39684 ...

Syneos Health
Brossard, QC Canada
  Connect »

Reference study Id Number: GS39684 ...

San Tan Allergy & Asthma
Gilbert, AZ United States
  Connect »

Reference study Id Number: GS39684 ...

Kern Allergy Med Clinic, Inc.
Bakersfield, CA United States
  Connect »

Reference study Id Number: GS39684 ...

Integrated Research Group Inc
Riverside, CA United States
  Connect »

Reference study Id Number: GS39684 ...

University of South Florida
Tampa, FL United States
  Connect »

Reference study Id Number: GS39684 ...

TTS Research
Boerne, TX United States
  Connect »

Reference study Id Number: GS39684 ...

ASTHMA Clinical Research Center
Seattle, WA United States
  Connect »

Reference study Id Number: GS39684 ...

Ottawa Allergy Research Corp
Ottawa, ON Canada
  Connect »

Reference study Id Number: GS39684 ...

Integrated Research of Inland
Upland, CA United States
  Connect »